TW201840299A - 玻尿酸複合奈米粒子 - Google Patents

玻尿酸複合奈米粒子 Download PDF

Info

Publication number: TW201840299A
Authority: TW; Taiwan
Prior art keywords: hyaluronic acid; composite nanoparticle; zwitterionic; present; polymer
Prior art date: 2017-03-30

Application number

TW107111567A

Other languages

English (en)

Chinese (zh)

Inventor

史

宮原令二

清水広子

Original Assignee

日商資生堂股份有限公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-03-30

Filing date

2018-03-30

Publication date

2018-11-16

2018-03-30 Application filed by 日商資生堂股份有限公司 filed Critical 日商資生堂股份有限公司

2018-11-16 Publication of TW201840299A publication Critical patent/TW201840299A/zh

Links

239000002105 nanoparticle Substances 0.000 title claims abstract description 74
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 73
229920002674 hyaluronan Polymers 0.000 title claims abstract description 73
229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 71
239000002131 composite material Substances 0.000 title claims abstract description 70
150000001875 compounds Chemical class 0.000 claims abstract description 42
239000002245 particle Substances 0.000 claims abstract description 27
229920000642 polymer Polymers 0.000 claims description 20
238000002156 mixing Methods 0.000 claims description 12
150000003839 salts Chemical class 0.000 claims description 11
229920001577 copolymer Polymers 0.000 claims description 9
238000002360 preparation method Methods 0.000 claims description 7
PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 claims description 6
239000013543 active substance Substances 0.000 claims description 5
229950004354 phosphorylcholine Drugs 0.000 claims description 3
239000011859 microparticle Substances 0.000 abstract description 5
KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 19
210000003491 skin Anatomy 0.000 description 19
239000000243 solution Substances 0.000 description 19
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
229960003237 betaine Drugs 0.000 description 11
239000000203 mixture Substances 0.000 description 10
238000003756 stirring Methods 0.000 description 8
229920001661 Chitosan Polymers 0.000 description 7
238000000034 method Methods 0.000 description 7
-1 sodium hyaluronic acid salt Chemical class 0.000 description 7
150000001449 anionic compounds Chemical class 0.000 description 6
229920006318 anionic polymer Polymers 0.000 description 6
239000000872 buffer Substances 0.000 description 6
239000010419 fine particle Substances 0.000 description 6
230000003020 moisturizing effect Effects 0.000 description 6
239000000047 product Substances 0.000 description 6
239000002904 solvent Substances 0.000 description 6
239000004480 active ingredient Substances 0.000 description 5
239000003240 coconut oil Substances 0.000 description 5
235000019864 coconut oil Nutrition 0.000 description 5
150000004665 fatty acids Chemical class 0.000 description 5
238000009472 formulation Methods 0.000 description 5
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
SOGAXMICEFXMKE-UHFFFAOYSA-N alpha-Methyl-n-butyl acrylate Natural products CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 4
229920006317 cationic polymer Polymers 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000000126 substance Substances 0.000 description 4
VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
HZNDZTXHJZSPRN-UHFFFAOYSA-N CC(C)=COCCOP([O-])(OCC[N+](C)(C)C)=O Chemical compound CC(C)=COCCOP([O-])(OCC[N+](C)(C)C)=O HZNDZTXHJZSPRN-UHFFFAOYSA-N 0.000 description 3
229920006322 acrylamide copolymer Polymers 0.000 description 3
125000005250 alkyl acrylate group Chemical group 0.000 description 3
239000002280 amphoteric surfactant Substances 0.000 description 3
239000002537 cosmetic Substances 0.000 description 3
235000014113 dietary fatty acids Nutrition 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000009881 electrostatic interaction Effects 0.000 description 3
229930195729 fatty acid Natural products 0.000 description 3
239000000194 fatty acid Substances 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
239000000178 monomer Substances 0.000 description 3
OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 3
HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 3
229920000058 polyacrylate Polymers 0.000 description 3
QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000000536 complexating effect Effects 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
238000010030 laminating Methods 0.000 description 2
239000003346 palm kernel oil Substances 0.000 description 2
235000019865 palm kernel oil Nutrition 0.000 description 2
229960005323 phenoxyethanol Drugs 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
238000005199 ultracentrifugation Methods 0.000 description 2
NCBISIFFSNXYQJ-UHFFFAOYSA-N 1-dodecyl-4,5-dihydroimidazole Chemical compound CCCCCCCCCCCCN1CCN=C1 NCBISIFFSNXYQJ-UHFFFAOYSA-N 0.000 description 1
GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
FIEMNCUPUKWJBC-UHFFFAOYSA-N 2-methylprop-1-ene-1-thiol Chemical compound CC(C)=CS FIEMNCUPUKWJBC-UHFFFAOYSA-N 0.000 description 1
229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
HGWMEBOCADNMGF-AWGDKMGJSA-N C(C)N[C@H]1C(O)(O[C@@H]([C@H]([C@@H]1O)O)CO)C1=CC=CC=2C3=CC=CC=C3CC12 Chemical group C(C)N[C@H]1C(O)(O[C@@H]([C@H]([C@@H]1O)O)CO)C1=CC=CC=2C3=CC=CC=C3CC12 HGWMEBOCADNMGF-AWGDKMGJSA-N 0.000 description 1
FRVJGSHGYZCQIY-UHFFFAOYSA-N CCC(C[N+](C)(C)C)OP([O-])(OCC)=O Chemical compound CCC(C[N+](C)(C)C)OP([O-])(OCC)=O FRVJGSHGYZCQIY-UHFFFAOYSA-N 0.000 description 1
241000561734 Celosia cristata Species 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
229920000045 Dermatan sulfate Polymers 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
229920000855 Fucoidan Polymers 0.000 description 1
229920000288 Keratan sulfate Polymers 0.000 description 1
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
229920000805 Polyaspartic acid Polymers 0.000 description 1
229920001100 Polydextrose Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
229920002385 Sodium hyaluronate Polymers 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
ATMLPEJAVWINOF-UHFFFAOYSA-N acrylic acid acrylic acid Chemical compound OC(=O)C=C.OC(=O)C=C ATMLPEJAVWINOF-UHFFFAOYSA-N 0.000 description 1
229920000800 acrylic rubber Polymers 0.000 description 1
238000005054 agglomeration Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical group O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
238000005576 amination reaction Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical group CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
229940045110 chitosan Drugs 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
229940059329 chondroitin sulfate Drugs 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
210000001520 comb Anatomy 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
229940051593 dermatan sulfate Drugs 0.000 description 1
PSHRANCNVXNITH-UHFFFAOYSA-N dimethylamino acetate Chemical compound CN(C)OC(C)=O PSHRANCNVXNITH-UHFFFAOYSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
238000006266 etherification reaction Methods 0.000 description 1
SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
238000000605 extraction Methods 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
235000013905 glycine and its sodium salt Nutrition 0.000 description 1
229940116364 hard fat Drugs 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
238000005907 ketalization reaction Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
108010064470 polyaspartate Proteins 0.000 description 1
239000001259 polydextrose Substances 0.000 description 1
229940035035 polydextrose Drugs 0.000 description 1
235000013856 polydextrose Nutrition 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
238000001338 self-assembly Methods 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
239000000344 soap Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229940010747 sodium hyaluronate Drugs 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1
239000002888 zwitterionic surfactant Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Birds (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Cosmetics (AREA)

TW107111567A 2017-03-30 2018-03-30 玻尿酸複合奈米粒子 TW201840299A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2017-068605		2017-03-30
JP2017068605		2017-03-30

Publications (1)

Publication Number	Publication Date
TW201840299A true TW201840299A (zh)	2018-11-16

Family

ID=63677796

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW107111567A TW201840299A (zh)	2017-03-30	2018-03-30	玻尿酸複合奈米粒子

Country Status (2)

Country	Link
TW (1)	TW201840299A (ja)
WO (1)	WO2018182003A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP4018998A4 (en) *	2019-08-21	2023-09-27	Shiseido Company, Ltd.	COSMETIC PRODUCT
TW202245732A (zh)	2021-02-10	2022-12-01	日商資生堂股份有限公司	化妝料
CN113952506B (zh) *	2021-09-26	2023-03-21	华南理工大学	一种仿生软骨表层修复水凝胶的制备方法
CN120152695A (zh)	2022-12-01	2025-06-13	株式会社资生堂	组合物
WO2025173703A1 (ja) *	2024-02-13	2025-08-21	ワミレスコスメティックス株式会社	化粧料

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003073251A (ja) *	2001-08-31	2003-03-12	Shiseido Co Ltd	皮膚外用剤
JP5412078B2 (ja) *	2008-10-06	2014-02-12	ドクタープログラム株式会社	皮膚外用剤
JP2010150151A (ja) *	2008-12-24	2010-07-08	Hosokawa Micron Corp	ヒアルロン酸担持ナノ粒子及びヒアルロン酸含有複合粒子並びにそれらを用いた化粧料
JP2013159605A (ja) *	2012-02-09	2013-08-19	Shiseido Co Ltd	皮膚外用剤組成物
US10357437B2 (en) *	2015-03-13	2019-07-23	Nof Corporation	Composition for nanoemulsion emulsification, bicontinuous microemulsion, cosmetic, and method for producing same

2018
- 2018-03-30 TW TW107111567A patent/TW201840299A/zh unknown
- 2018-03-30 WO PCT/JP2018/013947 patent/WO2018182003A1/ja not_active Ceased

Also Published As

Publication number	Publication date
WO2018182003A1 (ja)	2018-10-04

Publication	Publication Date	Title
TW201840299A (zh)	2018-11-16	玻尿酸複合奈米粒子
CN102665656B (zh)	2014-03-12	O/w型乳化化妆品
CN105209008B (zh)	2017-10-13	皮肤清洁剂
WO2018074237A1 (ja)	2018-04-26	アニオン性ポリマー及びカチオン性ポリマー若しくはペプチドを含む複合粒子並びにその製造方法
BR112012007486B1 (pt)	2022-08-02	Co-polímero anfifílico super-hidrofílico e processo para fazer um co-polímero anfifílico super-hidrofílico
TWI507217B (zh)	2015-11-11	Disperse powder disperse cosmetic
KR20170050390A (ko)	2017-05-11	음전하 물질을 포함하는 미세먼지 방진용 조성물
CA2716702A1 (en)	2011-04-07	Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof
WO2012169518A1 (ja)	2012-12-13	液状組成物及びそれを用いた化粧料並びに育毛剤
US20120201862A1 (en)	2012-08-09	Process for the preparation of colloidal systems for the delivery of active compounds
TW201929836A (zh)	2019-08-01	防微塵組成物
JP7536018B2 (ja)	2024-08-19	化粧料
JP5114089B2 (ja)	2013-01-09	乳液状皮膚化粧料
JP2011168583A (ja)	2011-09-01	外用剤組成物
JP2014526478A (ja)	2014-10-06	低粘度パーソナルケア組成物
JP5840838B2 (ja)	2016-01-06	増粘性組成物およびその製造方法
CN101080212A (zh)	2007-11-28	包含聚合乳化剂的清洁组合物及其使用方法
JP2017066046A (ja)	2017-04-06	ヒアルロナンを含む複合粒子を含有する乳化組成物
JP2021165301A (ja)	2021-10-14	アニオン性ポリマー及びカチオン性ポリマーを含む複合粒子
JP6283570B2 (ja)	2018-02-21	ポリイソブチレンエマルジョンの製造方法
JP2001354820A (ja)	2001-12-25	複合エマルジョン及びこれを配合した化粧料
EP2942063A1 (en)	2015-11-11	Composition for fluidizing mucus comprising chitosan and copolymers
JP2025094841A (ja)	2025-06-25	身体用水性組成物
HK40077922B (zh)	2024-07-19	含有阴离子聚合物和阳离子聚合物或肽的复合粒子及其制造方法
Reeta et al.	2019	Fabrication and Characterisation of Lavender Oil and Plant Phospholipid Based Sumatriptan Succinate Hybrid Nano Lipid Carriers. Pharmaceutical and Biomedical Research. 2020; 6 (1): 91-104